ZYBERNO
Stock Report
Updated Sep 1, 2026

AVAI BIO, INC. (AVAI)

Technology • OTC

$0.12

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
4.0/100
POOR BUSINESS
AVAI BIO, INC. (AVAI) scores 4/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-192.1%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

AVAI BIO, INC. (AVAI) stock report — Zyberno Score 4/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.12
Market Cap:$18.32M

Valuation Multiples (1)

Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$19.04M

Price Action & Momentum (3)

Momentum Percentile:2 / 100
% of 52-Week High:14.9%
B. Profitability Assessment

Return Metrics (4)

ROA:-410.2%
Reinvestment Rate:1.9%
Fundamental Growth Rate (g):-3.7%

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$8.03
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Cash Flow Growth (Linear) (1)

Operating Cash Flow Growth Rate (Linear):-3.9%

Operating Growth (Linear) (1)

Operating Income Growth Rate (Linear):74.5%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.04x
Quick Ratio:0.04x
Cash Ratio:0.02x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:-3,860,035.00
Cash And Cash Equivalents:83,586.00
Long Term Debt:$0.00
Net Debt:$719.39K
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$0.00
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00
Operating income TTM: -$1.81M
Linear Growth: 74.5%
📊 Click to view full AVAI Operating Income analysis & methodology →

Bottom Line Performance (3)

-$1.81M
Income Before Tax:-$452.30K
Ebitda Ttm:-1,789,165.00

Operating Expenses (5)

Operating Expenses:1,412,385.00
R And D Expense:23,804.00
Sga Expense:754,859.00
Income Tax Expense:$0.00
Interest Expense:-4,500.00

Expense Ratios (1)

Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$791.75K
Current Assets:$154.28K
Ppe Net:1,500.00
Goodwill:0.00
Intangible Assets:$158.90K

Liability Structure (4)

Total Liabilities:4,014,316.00
Current Liabilities:4,014,316.00
Long Term Debt:$0.00
Short Term Debt:$802.97K

Equity & Capital (3)

Equity:-$3.22M
Retained Earnings:-$6.42M
Common Stock:500,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:1,729,921.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: -$1.18M
Linear Growth: -3.9%
$0.00

Investment Activities (1)

Investing Cash Flow:-$58.60K

Financing Activities (3)

Financing Cash Flow:$533.30K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:705.00
Long Term Debt Issuance:$140.00K
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:24,796.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.01
$0.00
Earnings Per Share Ttm:-$0.01

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$0.01

Book Value & Capital (2)

Book Value Per Share:-$0.02
Cash Per Share:0.00

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (1)

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:10.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:1.9%
Fundamental Growth Rate (g):-3.7%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Operating Income Growth Rate (Linear):74.5%

Cash Flow Growth Rates (1)

Operating Cash Flow Growth Rate (Linear):-3.9%

Other Growth Rates (1)

Book Value Growth Rate (Linear):100.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:AVAI
Company Name:AVAI BIO, INC.
Sector:Technology
Industry:Data Services
Exchange:OTC
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:153.92M
Shares Outstanding Basic:153.92M
Shares Outstanding Diluted:26.28M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 11:13:35 UTC
Data Timestamp:2026-08-21T03:07:35.778078
Scroll to Top